{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:25:40Z","timestamp":1776486340214,"version":"3.51.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03253-z","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T04:01:39Z","timestamp":1721620899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Plasma rich in growth factors (PRGF) technology as adjuvant to Ab Externo trabeculectomy"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1512-4180","authenticated-orcid":false,"given":"J. M.","family":"Pereira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. C.","family":"Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,22]]},"reference":[{"issue":"4","key":"3253_CR1","first-page":"74","volume":"36","author":"RJ Miron","year":"2017","unstructured":"Miron RJ, Bishara M, Choukroun J (2017) Basics of platelet-rich fibrin therapy. Dent Today 36(4):74\u201376","journal-title":"Dent Today"},{"key":"3253_CR2","first-page":"529","volume":"14","author":"E Anitua","year":"1999","unstructured":"Anitua E (1999) Plasma rich in growth factors: preliminary results of use in the preparation of sites for implants. Int J Oral Maxillofac Implants 14:529\u2013535","journal-title":"Int J Oral Maxillofac Implants"},{"issue":"5","key":"3253_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.tibtech.2006.02.010","volume":"24","author":"E Anitua","year":"2006","unstructured":"Anitua E, S\u00e1nchez M, Nurden AT, Nurden P, Orive G, And\u00eda I (2006) New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol 24(5):227\u2013234","journal-title":"Trends Biotechnol"},{"issue":"2","key":"3253_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.tips.2007.10.010","volume":"29","author":"E Anitua","year":"2008","unstructured":"Anitua E, S\u00e1nchez M, Orive G, Andia I (2008) Delivering growth factors for therapeutics. Trends Pharmacol Sci 29(2):37\u201341","journal-title":"Trends Pharmacol Sci"},{"key":"3253_CR5","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2021.1945030","author":"E Anitua","year":"2021","unstructured":"Anitua E, de la Sen-Corcuera B, Orive G, S\u00e1nchez-\u00c1vila RM, Heredia P, Muruzabal F, Merayo-Lloves J (2021) Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus. Expert Opin Biol Ther. https:\/\/doi.org\/10.1080\/14712598.2021.1945030","journal-title":"Expert Opin Biol Ther"},{"key":"3253_CR6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.exer.2015.02.016","volume":"135","author":"E Anitua","year":"2015","unstructured":"Anitua E, de la Fuente M, Muruzabal F et al (2015) Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts. Exp Eye Res 135:118\u2013126","journal-title":"Exp Eye Res"},{"key":"3253_CR7","doi-asserted-by":"publisher","first-page":"6066","DOI":"10.1167\/iovs.11-7302","volume":"52","author":"E Anitua","year":"2011","unstructured":"Anitua E, Sanchez M, Merayo-Lloves J et al (2011) Plasma rich in growth factors (PRGF-Endoret) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts and inhibits and reverts TGF-beta1-Induced myodifferentiation. Invest Ophthalmol Vis Sci 52:6066\u20136073","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3253_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.exer.2013.07.007","volume":"115","author":"E Anitua","year":"2013","unstructured":"Anitua E, Muruzabal F, Alcalde I et al (2013) Plasma rich in growth factors (PRGF-Endoret) stimulates corneal wound healing and reduces haze formation after PRK surgery. Exp Eye Res 115:153\u2013161","journal-title":"Exp Eye Res"},{"issue":"7\u20138","key":"3253_CR9","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.addr.2010.01.001","volume":"62","author":"E Anitua","year":"2010","unstructured":"Anitua E, S\u00e1nchez M, Orive G (2010) Potential of endogenous regenerative technology for in situ regenerative medicine. Adv Drug Deliv Rev 62(7\u20138):741\u2013752","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"3253_CR10","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1177\/1120672120960340","volume":"31","author":"MS Figueroa","year":"2021","unstructured":"Figueroa MS, Mora Cantallops A, Virgili G, Govetto A (2021) Long-term results of autologous plasma as adjuvant to pars plana vitrectomy in the treatment of high myopic full-thickness macular holes. Eur J Ophthalmol 31(5):2612\u20132620","journal-title":"Eur J Ophthalmol"},{"key":"3253_CR11","first-page":"229","volume":"12","author":"RM S\u00e1nchez-\u00c1vila","year":"2019","unstructured":"S\u00e1nchez-\u00c1vila RM, Fern\u00e1ndez-Vega Gonz\u00e1lez \u00c1, Fern\u00e1ndez-Vega Sanz \u00c1, Merayo-Lloves J (2019) Treatment of recurrent myopic macular hole using membrane of plasma rich in growth factors. Int Med Case Rep J 12:229\u2013233","journal-title":"Int Med Case Rep J"},{"key":"3253_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/ICB.0000000000000957","author":"JD Arias","year":"2019","unstructured":"Arias JD, Hoyos AT, Alc\u00e1ntara B, Sanchez-Avila RM, Arango FJ, Galvis V (2019) Plasma rich in growth factors for persistent macular hole: a pilot study. Retin Cases Brief Rep. https:\/\/doi.org\/10.1097\/ICB.0000000000000957","journal-title":"Retin Cases Brief Rep"},{"key":"3253_CR13","first-page":"97","volume":"11","author":"RM S\u00e1nchez-Avila","year":"2018","unstructured":"S\u00e1nchez-Avila RM, Merayo-Lloves J, Fern\u00e1ndez ML et al (2018) Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma. Int Med Case Rep J 11:97\u2013103","journal-title":"Int Med Case Rep J"},{"issue":"4","key":"3253_CR14","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.ophtha.2011.09.043","volume":"119","author":"J Landers","year":"2012","unstructured":"Landers J, Martin K, Sarkies N, Bourne R, Watson P (2012) A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology 119(4):694\u2013702","journal-title":"Ophthalmology"},{"issue":"3","key":"3253_CR15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00061198-200106000-00017","volume":"10","author":"DC Broadway","year":"2001","unstructured":"Broadway DC, Chang LP (2001) Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma 10(3):237\u2013249","journal-title":"J Glaucoma"},{"key":"3253_CR16","doi-asserted-by":"crossref","unstructured":"Cabourne E, Clarke JCK, Schlottmann PG, Evans JR (2015) Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery. Cochrane Database of Systematic Reviews 2015, Issue 11. Art. No.: CD006259","DOI":"10.1002\/14651858.CD006259.pub2"},{"issue":"1","key":"3253_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5005\/jp-journals-10028-1239","volume":"12","author":"J Lu","year":"2018","unstructured":"Lu J, Hall L, Liu J (2018) Improving Glaucoma Surgical Outcomes with Adjunct Tools. J Curr Glaucoma Pract 12(1):19\u201328","journal-title":"J Curr Glaucoma Pract"},{"issue":"6","key":"3253_CR18","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/00061198-200412000-00005","volume":"13","author":"AP Wells","year":"2004","unstructured":"Wells AP, Crowston JG, Marks J, Kirwan JF, Smith G, Clarke JC, Shah R, Vieira J, Bunce C, Murdoch I, Khaw PT (2004) A pilot study of a system for grading of drainage blebs after glaucoma surgery. J Glaucoma 13(6):454\u2013460","journal-title":"J Glaucoma"},{"issue":"1","key":"3253_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000481535","volume":"59","author":"I Rodr\u00edguez-Agirretxe","year":"2018","unstructured":"Rodr\u00edguez-Agirretxe I, Freire V, Muruzabal F, Orive G, Anitua E, D\u00edez-Feij\u00f3o E, Acera A (2018) Subconjunctival PRGF fibrin membrane as an adjuvant to nonpenetrating deep sclerectomy: A 2-Year pilot study. Ophthalmic Res 59(1):45\u201352. https:\/\/doi.org\/10.1159\/000481535","journal-title":"Ophthalmic Res"},{"key":"3253_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002897","author":"M Wilkins","year":"2001","unstructured":"Wilkins M, Indar A, Wormald R (2001) Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD002897","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"3253_CR21","first-page":"182","volume":"8","author":"R Daneshvar","year":"2013","unstructured":"Daneshvar R (2013) Anti-VEGF Agents and Glaucoma Filtering Surgery. J Ophthalmic Vis Res 8(2):182\u2013186","journal-title":"J Ophthalmic Vis Res"},{"key":"3253_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1645269","author":"M Slabaugh","year":"2017","unstructured":"Slabaugh M, Salim S (2017) Use of anti-VEGF agents in glaucoma surgery. J Ophthalmol. https:\/\/doi.org\/10.1155\/2017\/1645269","journal-title":"J Ophthalmol"},{"issue":"6","key":"3253_CR23","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3390\/ph16060898","volume":"16","author":"D Collotta","year":"2023","unstructured":"Collotta D, Colletta S, Carlucci V, Fruttero C, Fea AM, Collino M (2023) Pharmacological approaches to modulate the scarring process after glaucoma surgery. Pharmaceuticals 16(6):898","journal-title":"Pharmaceuticals"},{"issue":"10","key":"3253_CR24","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.4103\/ijo.IJO_3506_20","volume":"69","author":"VJ Chelerkar","year":"2021","unstructured":"Chelerkar VJ, Agrawal D, Kalyani VKS, Deshpande M (2021) Comparison of bleb morphology by anterior segment optical coherence tomography and clinical outcome after phacotrabeculectomy with mitomycin C or Ologen implant. Indian J Ophthalmol 69(10):2734\u20132739","journal-title":"Indian J Ophthalmol"},{"issue":"2020","key":"3253_CR25","doi-asserted-by":"publisher","first-page":"3949735","DOI":"10.1155\/2020\/3949735","volume":"9","author":"TY Shen","year":"2020","unstructured":"Shen TY, Hu WN, Cai WT, Jin HZ, Yu DH, Sun JH, Yu J (2020) Effectiveness and safety of trabeculectomy along with amniotic membrane transplantation on glaucoma: a systematic review. J Ophthalmol 9(2020):3949735. https:\/\/doi.org\/10.1155\/2020\/3949735","journal-title":"J Ophthalmol"},{"issue":"1","key":"3253_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jconrel.2011.07.004","volume":"157","author":"E Anitua","year":"2012","unstructured":"Anitua E, Alkhraisat MH, Orive G (2012) Perspectives and challenges in regenerative medicine using plasma rich in growth factors. J Control Release 157(1):29\u201338. https:\/\/doi.org\/10.1016\/j.jconrel.2011.07.004","journal-title":"J Control Release"},{"issue":"6","key":"3253_CR27","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2174\/1389201017666160301104139","volume":"17","author":"E Anitua","year":"2016","unstructured":"Anitua E, Pino A, Jaen P, Orive G (2016) Plasma rich in growth factors enhances wound healing and protects from photo-oxidative stress in dermal fibroblasts and 3D skin models. Curr Pharm Biotechnol 17(6):556\u2013570","journal-title":"Curr Pharm Biotechnol"},{"issue":"5","key":"3253_CR28","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.ophtha.2018.02.003","volume":"125","author":"SJ Gedde","year":"2018","unstructured":"Gedde SJ, Feuer WJ, Shi W, Lim KS, Barton K, Goyal S, Ahmed K, Brandt J (2018) Primary tube versus trabeculectomy study group. Treatment outcomes in the primary tube versus trabeculectomy study after 1 year of follow up. Ophthalmology 125(5):650\u2013663","journal-title":"Ophthalmology"},{"issue":"1","key":"3253_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ophtha.2005.06.037","volume":"113","author":"AP Wells","year":"2006","unstructured":"Wells AP, Ashraff NN, Hall RC, Purdie G (2006) Comparison of two clinical Bleb grading systems. Ophthalmology 113(1):77\u201383","journal-title":"Ophthalmology"},{"issue":"3","key":"3253_CR30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ajo.2010.03.025","volume":"150","author":"MY Kahook","year":"2010","unstructured":"Kahook MY (2010) Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot study. Am J Ophthalmol 150(3):399-403.e1","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"3253_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ajo.2010.09.004","volume":"151","author":"TJ Good","year":"2011","unstructured":"Good TJ, Kahook MY (2011) Assessment of bleb morphologic features and postoperative outcomes after Ex-PRESS drainage device implantation versus trabeculectomy. Am J Ophthalmol 151(3):507-513.e1","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"3253_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000481535","volume":"59","author":"I Rodr\u00edguez-Agirretxe","year":"2018","unstructured":"Rodr\u00edguez-Agirretxe I, Freire V, Muruzabal F, Orive G, Anitua E, D\u00edez-Feij\u00f3o E, Acera A (2018) Subconjunctival PRGF fibrin membrane as an adjuvant to nonpenetrating deep sclerectomy: A 2-year pilot study. Ophthalmic Res 59(1):45\u201352","journal-title":"Ophthalmic Res"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03253-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03253-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03253-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:47:49Z","timestamp":1741880869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03253-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3253"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03253-z","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,22]]},"assertion":[{"value":"26 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"332"}}